Pharmaceuticals

Inactivated Vaccines Global Forecast: Market to Scale Up to $8.07 Billion by 2030 at 5.1% CAGR

February 16, 2026March 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the inactivated vaccines market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Inactivated Vaccines Market from 2026 to 2030?

The inactivated vaccines market has demonstrated steady growth in size over recent years. It is anticipated to grow from $6.37 billion in 2025 to $6.61 billion in 2026, with a compound annual growth rate (CAGR) of 3.9%. This past growth can be attributed to an increasing prevalence of infectious diseases, advancements in virology research, government funding for immunization efforts, the expansion of healthcare infrastructure, and public awareness campaigns promoting vaccination.

The inactivated vaccines market is projected to experience substantial expansion over the forthcoming years. This market is anticipated to reach $8.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth during the forecast period include a rising elderly population, improved healthcare accessibility in emerging markets, progress in vaccine delivery technologies, a surge in worldwide immunization efforts, and the increasing use of multi-dose and combination vaccines. Key trends for the forecast period encompass innovations in vaccine formulation, the broadening of cold chain logistics, a heightened demand for pediatric vaccines, the expansion of governmental immunization programs, and the creation of combination vaccines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

What Drivers Are Affecting Demand In The Inactivated Vaccines Market?

The expanding occurrence of infectious diseases is anticipated to boost the development of the inactivated vaccine market in the future. These illnesses originate from pathogens like bacteria, viruses, fungi, or parasites, which are transmissible between individuals and lead to diverse symptoms and health issues. Tuberculosis represents a form of infectious disease. Non-living pathogens are employed in inactivated vaccines to trigger an immune response, thereby preventing conditions like polio, hepatitis A, and influenza. For example, as reported by an article from the US-based national public health agency, Centers for Disease Control and Prevention, in November 2023, the count of tuberculosis patients in the USA rose from 8,320 in 2022 to 9,615 in 2023, marking an increment of 1,295 cases. Consequently, the rising occurrence of infectious diseases is stimulating the expansion of the inactivated vaccine market.

Which Segment Groups Are Influencing The Inactivated Vaccines Market?

The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

What Upcoming Trends Are Likely To Define The Future Path Of The Inactivated Vaccines Market?

Leading companies in the inactivated vaccines market are concentrating on increasing product introductions and acquiring regulatory clearances to bolster their global vaccine collections and satisfy increasing immunization demands. For instance, in April 2024, Sanofi S.A., a healthcare firm based in France, launched Verorab, its inactivated rabies vaccine, in the UK, suitable for all age groups in both pre-exposure and post-exposure scenarios. This introduction emphasizes the company’s continuous efforts to expand its assortment of inactivated vaccines and reinforce its worldwide immunization provisions. The action further reflects escalating investments and growing regulatory drive surrounding the development and approval of inactivated vaccines. As more companies advance similar products and diversify their portfolios, these calculated strategies are collectively fostering significant expansion within the inactivated vaccines market, supporting broader protection against infectious diseases.

Who Are The Primary Competitors In The Global Inactivated Vaccines Market?

Major companies operating in the inactivated vaccines market are Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Inactivated Vaccines Market?

North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Inactivated Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2026, By The Business Research Company

Inactivated Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795